Streetbeat News

Earnings

DHX

DHI Group, Inc. reported its 2024 Q3 financial results, showing a 6% decline in total revenue year-over-year. ClearanceJobs revenue increased by 6%, while Dice revenue decreased by 12%. Total bookings fell by 7%. The company also announced a CFO transition.

Portfolio Pulse from

November 12, 2024 | 9:30 pm

EXOD

Exodus Movement, Inc. (OTCQX: EXOD) announced its third quarter 2024 results, highlighting its position as a leading self-custodial cryptocurrency software platform.

Portfolio Pulse from

November 12, 2024 | 9:30 pm

SMTI

Sanara MedTech Inc. (Nasdaq: SMTI) reported its third quarter 2024 results, highlighting strategic, operational, and financial outcomes. The company focuses on medical technologies for surgical, chronic wound, and skincare markets.

Portfolio Pulse from

November 12, 2024 | 9:30 pm

TTGT

TechTarget, Inc. (Nasdaq: TTGT) has announced its financial results for the third quarter of 2024, ending on September 30, 2024. The results have been posted on their website.

Portfolio Pulse from

November 12, 2024 | 9:30 pm

FBLG

FibroBiologics has reported its third quarter 2024 financial results and provided a corporate update. The company is preparing for a Phase 1/2 clinical trial in Australia for its fibroblast-based spheroids product candidate, CYWC628, aimed at treating diabetic foot ulcers, with plans to start in Q2 2025.

Portfolio Pulse from

November 12, 2024 | 9:30 pm

CXAI

CXApp Inc. (Nasdaq: CXAI) reported its Q3 2024 financial results, showcasing the highest SaaS metrics to date. The company achieved an 18% increase in recurring revenue, a net retention rate of 106%, and 88% of revenue from subscriptions, with a total recognized revenue of $1.9M and an 80% gross margin. CXAI is also available on AWS Marketplace, indicating potential for continued growth.

Portfolio Pulse from

November 12, 2024 | 9:30 pm

SURG

SurgePays, Inc. (Nasdaq: SURG) announced its financial results for Q3 2024, highlighting the ongoing migration of former ACP subscribers to Lifeline.

Portfolio Pulse from

November 12, 2024 | 9:30 pm

OBIO

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) reported its third quarter 2024 financial results and provided a business update. The company focuses on accelerating high-impact biomedical technologies through partnerships.

Portfolio Pulse from

November 12, 2024 | 9:30 pm

EPM

Evolution Petroleum Corporation reported a 6% year-over-year increase in fiscal Q1 revenues to $21.9 million, driven by record oil production. Net income rose to $2.1 million, and adjusted EBITDA increased by 21% to $8.1 million. The company declared a quarterly cash dividend of $0.12 per share for the fiscal 2025 second quarter.

Portfolio Pulse from

November 12, 2024 | 9:30 pm

VRM

Vroom, Inc. (Nasdaq:VRM) reported its Q3 2024 financial results, highlighting a net loss of $37.7 million and an adjusted EBITDA of $25.5 million. The company has $51.1 million in cash and cash equivalents and $32.9 million in liquidity available to UACC. Vroom also announced a restructuring agreement for $290 million of unsecured convertible notes into equity.

Portfolio Pulse from

November 12, 2024 | 9:30 pm